Netanyahu Discloses Malignant Prostate Tumor Treatment in Annual Health Assessment Following Months of Speculation

Israeli PM Benjamin Netanyahu discloses treatment for an early-stage malignant tumor in his 2026 health report, debunking rumors of poor health.

By: AXL Media

Published: Apr 24, 2026, 7:39 AM EDT

Source: Information for this report was sourced from Times of Israel

A Delayed Disclosure Amid Regional Instability

Prime Minister Benjamin Netanyahu’s latest medical report has brought an end to months of intense public speculation regarding his health. In a lengthy statement shared on social media, Netanyahu admitted that a routine check-up following his December 2024 surgery for benign prostate enlargement led to the discovery of a "tiny spot" less than a centimeter in size. Biopsy results confirmed a malignant tumor in its very early stages. The Prime Minister explained that he chose to delay the publication of this information by two months to prevent adversaries, specifically the Iranian regime, from exploiting the news for "false propaganda" during a period of high regional tension.

Surgical Intervention and Treatment Decisions

Upon receiving the diagnosis, Netanyahu’s medical team reportedly offered him the option of active surveillance, a common strategy for low-grade, early-stage prostate malignancies. However, the Prime Minister rejected this wait-and-see approach, stating that his philosophy on personal health mirrors his national security strategy: identifying threats early and neutralizing them immediately. Netanyahu confirmed that he underwent "targeted treatment" that successfully removed the malignant tissue. His doctors noted in the final report that the procedure left "no trace" of the malignancy and that there were no signs of metastasis or spread beyond the original site.

Comprehensive Vital Signs and Cardiac Stability

Despite the revelation of the tumor, the 2026 health assessment provides a largely positive outlook on the Prime Minister's physical condition. All laboratory results, including blood counts, liver and kidney function, and electrolyte levels, were found to be within normal ranges. Special attention was given to Netanyahu’s cardiac health, following the emergency implantation of a pacemaker in July 2023. According to Professor Roy Beinart, the Prime Minister's heart is "completely stable" and requires no treatment beyond standard routine monitoring. The report emphasizes that there are no cardiac restrictions on Netanyahu's professional duties or physical exercise routines.